Figure 1 Arestin used in the study

Figure 2 Application of the minocycline at the test site.

Control sites

Minocycline sites

Clinical parameters

At 6
 months

At 3 months

Baseline

At 6 months

At 3 months

Baseline

0.85 ±
 0.15

1.15 ± 0.25

2.58 ± 0.36

0.71 ± 0.25

1.06 ± 0.29

2.46 ± 0.54

Mean ±
SD

Plaque index

32.50

33.17

50.35

33.45

35.77

 

52.12

Percentage (%)

Bleeding upon probing index

Table1 Plaque index and bleeding upon probing values of minocycline sites versus control sites at time intervals.

Values are expressed as mean ± SD and percentage

Control sites

Minocycline sites

Clinical parameters

At 6 months

At 3 months

Baseline

At 6 months

At 3 months

Baseline

4-6

4-7

5-8

4-6

4-6

5-8

Range

Probing  pocket depth

5.58±0.41

5.9±0.6

6.53±0.34

4.4±0.4 *

4.8±0.7 *

6.28±0.5

Mean ±SD

4-7

5-8

5-8

4-7

4-8

5-9

Range

Clinical Attachment level

6.45±0.7

6.4±0.3

6.9±04

5.7±0.15 *

5.75±0.35 *

6.8 ±0.2

Mean ±SD

Table2 The probing pocket depth and clinical attachment level of the minocycline sites versus control sites at time intervals

Values are expressed as range and mean ± SD (* indicates statistical significance at P < 0.05).